The U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday that Moderna’s Covid-19 vaccine may pose a higher risk of heart inflammation in certain age groups compared to Pfizer-BioNTech’s shot.
According to data from the Vaccine Safety Datalink (VSD) system, the incidence of heart inflammation was 97.3 cases per million doses for males aged 18-39 following the second dose of Moderna’s shot, versus 81.7 cases per million Pfizer vaccine doses.
Moderna COVID-19 vaccine received U.S. Food and Drug Administration (FDA) approval on January 31, 2022, for individuals ages 18 years and older. The Moderna COVID-19 vaccine is branded under the name Spikevax.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.